Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Metastasis02:30

Metastasis

6.7K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
6.7K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

6.2K
Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.2K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Cediranib with weekly paclitaxel or olaparib versus weekly paclitaxel for advanced or recurrent endometrial cancer (COPELIA): a multicentre, open-label, randomised, phase 2 trial in the UK.

EClinicalMedicine·2026
Same author

Advancing the applications of liquid biopsies in oncology.

Nature reviews. Genetics·2026
Same author

Use of circulating tumour DNA to prospectively guide a switch from targeted to immune therapy in BRAF mutant advanced melanoma: the randomised phase II CAcTUS trial.

Nature communications·2026
Same author

Cell-free DNA methylome and fragmentome analysis for relapse monitoring of Ewing sarcoma.

EMBO molecular medicine·2026
Same author

Abrogation of Oncogenic RAS Signaling by a RAS(ON) Inhibitor Doublet Primes Immune-Refractory KRASG12C-Mutant NSCLC for Immune Checkpoint Blockade.

Cancer discovery·2026
Same author

Expression of Concern: Application of Sequencing, Liquid Biopsies, and Patient-Derived Xenografts for Personalized Medicine in Melanoma.

Cancer discovery·2026

Related Experiment Video

Updated: Mar 7, 2026

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
07:32

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

Published on: June 15, 2012

27.3K

SnapShot: Circulating Tumor Cells.

Caroline Dive1, Ged Brady1

  • 1Cancer Research UK Manchester Institute, University of Manchester, Manchester M20 4BX, UK.

Cell
|February 11, 2017
PubMed
Summary

Circulating tumor cells (CTCs) signal cancer presence and metastasis risk. Advanced technology allows CTC analysis for cancer biology insights and new blood biomarker development.

Area of Science:

  • Oncology
  • Molecular Biology
  • Biomarker Discovery

Background:

  • Circulating tumor cells (CTCs) are present in the bloodstream of cancer patients.
  • CTCs indicate the presence of a primary tumor and the potential for metastasis.
  • Analyzing CTCs offers insights into cancer progression and treatment response.

Purpose of the Study:

  • To highlight the significance of CTCs as indicators of cancer and metastasis.
  • To discuss the role of technological advancements in CTC isolation and analysis.
  • To explore the potential of CTCs in developing novel blood-based biomarkers for cancer.

Main Methods:

  • Review of recent technological developments in CTC isolation techniques.
  • Analysis of studies focusing on the biological insights gained from CTCs.

More Related Videos

Capture and Release of Viable Circulating Tumor Cells from Blood
08:10

Capture and Release of Viable Circulating Tumor Cells from Blood

Published on: October 28, 2016

9.0K
Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
07:47

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Published on: December 25, 2021

4.7K

Related Experiment Videos

Last Updated: Mar 7, 2026

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples
07:32

Rapid Isolation of Viable Circulating Tumor Cells from Patient Blood Samples

Published on: June 15, 2012

27.3K
Capture and Release of Viable Circulating Tumor Cells from Blood
08:10

Capture and Release of Viable Circulating Tumor Cells from Blood

Published on: October 28, 2016

9.0K
Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research
07:47

Circulating Tumor Cell Lines: an Innovative Tool for Fundamental and Translational Research

Published on: December 25, 2021

4.7K
  • Exploration of current and future applications of CTCs in biomarker development.

    • Main Results:

    • CTCs serve as crucial indicators for tumor detection and metastatic potential.
    • Technological progress enables more effective isolation and characterization of CTCs.
    • CTC analysis provides valuable data on cancer biology, treatment efficacy, and resistance mechanisms.

    Conclusions:

    • Circulating tumor cells are vital for understanding cancer spread and patient prognosis.
    • Advancements in CTC analysis open new diagnostic and therapeutic monitoring avenues.
    • CTCs represent a promising frontier for non-invasive blood biomarker development in oncology.